The groundbreaking therapy of the medication represents a major development in the care of the condition. Different to existing medications, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – providing https://tirzepatidepeptide240646.yomoblog.com/49398462/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment